LPL Financial LLC Sells 17,049 Shares of DENTSPLY SIRONA Inc. $XRAY

LPL Financial LLC lowered its position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 14.8% in the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 98,059 shares of the medical instruments supplier’s stock after selling 17,049 shares during the period. LPL Financial LLC’s holdings in DENTSPLY SIRONA were worth $1,465,000 at the end of the most recent quarter.

Several other hedge funds also recently bought and sold shares of the company. Barclays PLC lifted its stake in DENTSPLY SIRONA by 13.8% in the 4th quarter. Barclays PLC now owns 349,112 shares of the medical instruments supplier’s stock worth $6,625,000 after purchasing an additional 42,303 shares in the last quarter. CANADA LIFE ASSURANCE Co lifted its stake in DENTSPLY SIRONA by 14.7% in the 4th quarter. CANADA LIFE ASSURANCE Co now owns 212,681 shares of the medical instruments supplier’s stock worth $4,034,000 after purchasing an additional 27,246 shares in the last quarter. First Trust Advisors LP lifted its stake in DENTSPLY SIRONA by 4.2% in the 4th quarter. First Trust Advisors LP now owns 270,363 shares of the medical instruments supplier’s stock worth $5,131,000 after purchasing an additional 10,980 shares in the last quarter. Dimensional Fund Advisors LP lifted its stake in DENTSPLY SIRONA by 21.9% in the 4th quarter. Dimensional Fund Advisors LP now owns 6,851,869 shares of the medical instruments supplier’s stock worth $130,045,000 after purchasing an additional 1,230,944 shares in the last quarter. Finally, MetLife Investment Management LLC lifted its stake in DENTSPLY SIRONA by 7.0% in the 4th quarter. MetLife Investment Management LLC now owns 112,113 shares of the medical instruments supplier’s stock worth $2,128,000 after purchasing an additional 7,351 shares in the last quarter. Institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Price Performance

Shares of XRAY stock opened at $14.66 on Friday. The company has a debt-to-equity ratio of 1.13, a current ratio of 1.69 and a quick ratio of 1.11. The company has a market capitalization of $2.92 billion, a P/E ratio of -3.09, a P/E/G ratio of 0.87 and a beta of 0.94. The company’s 50-day simple moving average is $15.27 and its two-hundred day simple moving average is $15.52. DENTSPLY SIRONA Inc. has a one year low of $12.16 and a one year high of $27.48.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings data on Thursday, August 7th. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.50 by $0.02. DENTSPLY SIRONA had a negative net margin of 25.85% and a positive return on equity of 16.33%. The firm had revenue of $936.00 million for the quarter, compared to the consensus estimate of $929.67 million. During the same period last year, the firm earned $0.49 earnings per share. The company’s quarterly revenue was down 4.9% on a year-over-year basis. DENTSPLY SIRONA has set its FY 2025 guidance at 1.800-2.000 EPS. As a group, equities analysts anticipate that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current year.

DENTSPLY SIRONA Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 10th. Stockholders of record on Friday, September 26th will be paid a dividend of $0.16 per share. The ex-dividend date is Friday, September 26th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 4.4%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is currently -13.50%.

Analysts Set New Price Targets

Several analysts have recently issued reports on the stock. Needham & Company LLC restated a “hold” rating on shares of DENTSPLY SIRONA in a research report on Monday, July 21st. Piper Sandler decreased their target price on shares of DENTSPLY SIRONA from $20.00 to $16.00 and set a “neutral” rating on the stock in a research report on Wednesday, April 30th. Wells Fargo & Company cut their price target on shares of DENTSPLY SIRONA from $16.00 to $15.00 and set an “equal weight” rating on the stock in a report on Friday, August 8th. Barrington Research cut their price target on shares of DENTSPLY SIRONA from $21.00 to $18.00 and set an “outperform” rating on the stock in a report on Friday, August 8th. Finally, Stifel Nicolaus cut their price target on shares of DENTSPLY SIRONA from $19.00 to $17.00 and set a “hold” rating on the stock in a report on Friday, August 8th. Two equities research analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the stock. According to MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $18.64.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.